Dr. Hou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave FL 3
The Hillman Cancer Center
Pittsburgh, PA 15232Phone+1 412-235-1020Fax+1 412-235-1030
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2003 - 2006
- Canton Medical Education Foundation/NEOMEDResidency, Internal Medicine, 2000 - 2003
- Henan Medicine UniversityClass of 1986
Certifications & Licensure
- CA State Medical License 2003 - Present
- PA State Medical License 2006 - 2024
- OH State Medical License 2000 - 2003
Clinical Trials
- Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects Start of enrollment: 2021 Sep 13
Roles: Contact
Publications & Presentations
PubMed
- Structural insight into CD20/CD3-bispecific antibodies by molecular modeling.Ze-Yu Sun, Tianjian Liang, Yiyang Zhang, GanQian Hou, Xiaojie Chu
Computers in Biology and Medicine. 2024-12-13 - Maintenance strategies for relapse prevention and treatment.Emily Geramita, Jing-Zhou Hou, Warren D Shlomchik, Sawa Ito
Hematology. American Society of Hematology. Education Program. 2024-12-06 - A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.Kevin Quann, Konstantinos Lontos, Alison Sehgal, Anastasios Raptis, Annie Im
Haematologica. 2024-12-01
Press Mentions
- Cells Are More Resilient to Environmental Changes Than Previously ThoughtMay 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: